Trump OMB science grant rule could upend Mass. research and more
Introduction to the Proposed Regulation
The Trump administration has proposed a new regulation that could significantly impact the way federal grants are awarded, potentially undermining global collaboration and slowing down medical research. This change could have far-reaching effects, particularly in Massachusetts, which receives the most NIH funding per capita.
The Impact on Medical Research
The proposed regulation could hinder the work of researchers like Albers, a neurologist at Mass General Brigham, who are working to develop new treatments for diseases like Alzheimer’s. By restricting international partnerships and allowing the executive branch to disregard external scientific reviews, the regulation could slow down the development of new treatments and cost lives.
The “Domestic-First” Approach
The new regulation prioritizes a “domestic-first” approach, which scrutinizes international collaborations and prohibits funding for work that involves countries deemed adversarial to American institutions. This could limit the ability of researchers to collaborate with international experts and access large sets of data from other countries, ultimately slowing down the pace of medical research.
Criticisms of the Proposed Regulation
Critics argue that the proposed regulation is a “brazen power grab” that could have far-reaching effects on any recipients of federal funding, including states and municipalities. The American Association for the Advancement of Science has spoken out against the proposal, saying it could undermine the integrity of the scientific research process.
The Potential Consequences
If the regulation is finalized, it could lead to a brain drain of scientists leaving the United States to continue their work elsewhere. Many commenters have expressed concerns about the restrictions on using funds to publish research and to attend academic conferences, where scientists exchange ideas. Others have said that they would consider leaving the United States if the rule goes into effect.
Pushback from Lawmakers
The proposed regulation has prompted pushback from lawmakers in both parties. Senate Democrats have sent a letter to Trump budget director Russell Vought urging him to rescind the proposal, while Senator Susan Collins, Republican of Maine, has asked Vought to extend the comment period. US Representative Jake Auchincloss, Democrat of Massachusetts, has called the proposed rule a “five-alarm fire for American science.”
The Potential for Legal Challenges
If the regulation is finalized, it is likely to trigger a flood of lawsuits. Legal challenges could argue that the new regulation is not consistent with existing laws or that parts of it violate the First Amendment. However, even if the regulation is watered down or held up by lawsuits, it could still have lasting effects, creating an environment of uncertainty for grantees and potentially slowing down medical research.
The Need for Congressional Action
Congress could vote to undo the rule, but Trump would need to sign it, and he likely won’t. To override a presidential veto, lawmakers would need a two-thirds supermajority vote in the House and the Senate. It is essential for lawmakers to take action to prevent the proposed regulation from going into effect and to protect the integrity of the scientific research process.
Conclusion
The proposed regulation has the potential to significantly impact the scientific research community, slowing down medical research and undermining global collaboration. It is essential for lawmakers, researchers, and the public to speak out against the proposal and to work together to protect the integrity of the scientific research process. The future of medical research and the health of the American people depend on it. Source: WorldNewsAPI | Read original